Gland Pharma Limited (NSE:GLAND)
India
· Delayed Price · Currency is INR 1,751.60
+16.70 (0.96%)
At close: Dec 5, 2025
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 288.59 billion as of December 5, 2025. Its market cap has decreased by -1.22% in one year.
Market Cap
288.59B
Enterprise Value
259.59B
Revenue
58.01B
Ranking
n/a
PE Ratio
36.51
Stock Price
1,751.60
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 288.59B, a decrease of -2.87%. That is a compound annual growth rate of -0.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 288.59B | -1.56% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | 382.04B | 28.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,331.52B |
| Divi's Laboratories | 1,718.51B |
| Cipla | 1,228.46B |
| Apollo Hospitals Enterprise | 1,033.74B |
| Zydus Lifesciences | 937.26B |
| Mankind Pharma | 910.34B |
| Aurobindo Pharma | 707.18B |
| Alkem Laboratories | 678.59B |